Blog

Keeping You Informed Of Your Legal Rights

 

Para español, haga clic a continuación.
Home | Increasingly Popular Testosterone Replacement Therapy Drugs Are Linked To Heart Attacks, Strokes, And Deaths

Increasingly Popular Testosterone Replacement Therapy Drugs Are Linked To Heart Attacks, Strokes, And Deaths

by | Mar 17, 2014 | Defective Product Accidents

UPDATE“FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products”

FDA MedWatch Alert issued on January 31, 2014

 “More Evidence Supporting A Link Between Testosterone Therapy And Higher Risk Of Cardiovascular-Related Events Such As Myocardial Infarctions Or Heart Attacks”

Some of the prescription testosterone drug products approved by the FDA and available for use to treat low testosterone, or “Low T” syndrome, include:

•AndroGel
•Androderm
•Axiron
•Bio-T-Gel
•Delatestryl
•Depo-Testosterone
•Fortesta
•Striant
•Testim
•Testopel

Testosterone replacement therapy (TRT) is also referred to as androgen replacement therapy (ART) and male hormone replacement therapy.

Unfortunately, while it is estimated that the number of middle-aged men in the U.S. getting testosterone treatment has more than tripled over the last decade, the long-term risks are largely unknown.

Men with certain cardiac conditions such as heart disease who are prescribed these testosterone replacement therapy medications face an increased risk of cardiovascular adverse events according to a medical study article, “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels”, published in the November 6, 2013 edition of the Journal of American Medical Association.

To put this rather alerting drug safety information about testosterone replacement therapy into context we look to a November 2013 medical news report,“‘Low T’ Tx Tied to Higher Stroke Risk in Veterans”:

Steven Nissen, MD, of the Cleveland Clinic, characterized the study results as a red flag that demands “attention not just from physicians but also from regulators.”

We will continue to report about testosterone therapy and its increased risk of death, heart attacks, and strokes — as well as how these “Low T” drugs like Axiron, AndroGel, and Testim became so popular — in our next article about this emerging drug safety issue. 

If you or someone you know has suffered a heart condition injury due to testosterone replacement therapy, contact Guldjian immediately for a free consultation at 800-385-4835

Google Rating
4.9
Based on 124 reviews
Yelp Rating
5.0
Based on 22 reviews
js_loader

Schedule a Free Consultation